Date Filed | Type | Description |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2023 |
4
| Carmona Richard H (Director) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
06/09/2023 |
4
| Granger Elder (Director) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
06/09/2023 |
4
| Armanino Andrew J. (Director) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
06/09/2023 |
4
| LAVIZZO-MOUREY RISA J (Director) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
06/09/2023 |
4
| Parker Geoffrey M. (Director) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
06/09/2023 |
4
| PERRY DAVID P (Executive Chairman) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.77, valued at
$11.6k
|
|
05/18/2023 |
4
| Granger Elder (Director) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Bought 600 shares
@ $0.8672, valued at
$520.3 |
|
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/17/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/02/2022 |
4
| Wynholds Kristin (Chief Product Officer) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 5,023 shares
@ $1.5385, valued at
$7.7k
Granted 3,781 shares
@ $1.241, valued at
$4.7k
|
|
12/02/2022 |
4
| Heinen Mark (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Granted 15,723 shares
@ $1.241, valued at
$19.5k
|
|
09/19/2022 |
4
| PERRY DAVID P (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Bought 10,844 shares
@ $1.994, valued at
$21.6k
Bought 39,156 shares
@ $2.068, valued at
$81k
|
|
09/15/2022 |
4
| KARBE FRANK (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Bought 50,000 shares
@ $2.0939, valued at
$104.7k
|
|
09/14/2022 |
4
| Heinen Mark (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Bought 23,868 shares
@ $1.94, valued at
$46.3k
Bought 26,132 shares
@ $1.94, valued at
$50.7k
|
|
07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/28/2022 |
4
| Heinen Mark (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Bought 2,281 shares
@ $1.7539, valued at
$4k
|
|
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Heinen Mark (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.
Txns:
| Bought 5,000 shares
@ $1.56, valued at
$7.8k
|
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|